Physicians Clinical Biochemistry Warsaw Near Me

4worldlovers: Company founded in 2002 in Warsaw, Poland, focuses on phase I, early clinical development, bioequivalence, and phase III studies.

In January 2021 MTZ Clinical Research joined Pratia. Pratia is a network of clinical research sites in Europe and is part of the Neuca Group.

Medical analysis at own certified medical analysis laboratory or at a central lab

Medical documentation (from protocol to clinical report, using calculations in SAS 9.4 and Phoenix WinNonlin v. 8.1)


Highly trained and experienced study team providing accurate, reliable, and consistent data

To ensure the safety of the participants, and ultimately of Patients, the conduct of all clinical research trials is performed in strict compliance with the highest international standards.

All members of the core team have extensive experience in clinical trials conduct either at research institutes, at biopharmaceutical companies or at international CROs in Europe, the US or Canada.

All members of the team are obliged to comply with ICH GCP requirements, EU, Polish legislation and Company’s Standard Operating Procedures (SOPs).

The investigators employed at MTZ Clinical Research powered by Pratia are experienced doctors with specializations in various fields of medicine and experience in conducting clinical trials.

The multidirectional knowledge of our doctors allows the company to conduct research with patients in various therapeutic areas as well as difficult research with healthy participants.

All investigators are obliged to comply with the principles of good clinical practice and the company’s high standards.

Conducted 280 clinical studies, among others first human applications (FIH), multiple applications (MAD), drug-related interactions (DDI) and proof of concept (POC)

Certified Early Phases Clinical Research Unit fulfilling the EU legislation requirements (Guidelines for Phase I clinical trials)

In August 2009, our company obtained a Certificate of Approval for a Quality Management System according to ISO 9001:2008.

A recent audit, which took place in June 2018 has confirmed functioning to management system in accordance with requirements new standard ISO 9001:2015. The Certificate is valid until August 2024.

Currently, the company has a certified quality management system for the following scope of operations: Conduct of contracted medical trials and operation of MTZ Clinical Research powered by Pratia Site. Medical services in the field of laboratory diagnostics in the Research Centre of MTZ Clinical Research powered by Pratia

Inspections focused on the conduct of bioequivalence trial and Phase III study and confirmed the compliance with GCP, local regulations and the study protocol.

MTZ Clinical Research powered by Pratia Unit (CRU) implements for its employees the training program “ICH E6 Good Clinical Practice for Investigators and Site Personnel” accredited by GCPpl and TransCelerate BioPharma Inc.

MTZ Clinical Research powered by Pratia Unit is a member of the global Society of Clinical Research Sites (SCRS)

4worldlovers:
We are pleased to inform you that the Institute has received funding from the National Agency for Academic Exchange for the implementation of the project “Welcome to IBB Center”. The aim of the project is to increase the internationalization of the Institute and to improve the quality of service for foreign scientific staff and students. The Center (…)

We are pleased to announce that Dr. Tomasz Włodarski has received a grant under the POLONEZ BIS program of the National Science Center. The research will be carried out in the Department headed by Prof. Piotr Zielenkiewicz. Congratulations and we wish you success in the implementation of your research. For more information: https://ncn.gov.pl/en/aktualnosci/2023-05-24-wyniki-polonez-bis3 POLONEZ (…)

We are happy to announce the successes of our scientists. Employees of the Institute of Biochemistry and Biophysics PAS received 5 grants in competitions of the National Science Centre OPUS 24, SONATA 18, PRELUDIUM BIS 4. In the OPUS 24 and SONATA 18 competitions, 3015 applications were submitted, of which 363 were selected for funding. (…)

4worldlovers: Rely on a clinical development partner with the accessible expertise to help you reach your milestones.

Clinical research isn’t a straight path. Let’s navigate it together.

At Worldwide, we believe a personalized approach is the only way to unlock the power of everyone working on a study – from operational and therapeutic experts to site partners and scientists. That means you’ll always have direct access to our experts. You’ll be able to tap into more than 30 years of therapeutic experience on a global scale. And your mission is our mission – we are dedicated to working with you to meet your goals.

When the FDA knocks, answer with AME study results for clinical trial success


Transformational Relationships: How a Consultative Approach from a CRO Adds Value to Your Development Program

Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease Patients

We were founded on an unwavering commitment to therapeutic excellence and personalized attention. And today, that’s more important than ever. That means you have access to our senior-level experts who will work directly with you. It means we listen to you, understand your study’s needs, and actively seek customized solutions that are tailored to your specific project – even if we need to pivot and adapt along the way.

Every study is different. Every path forward is different. And we will partner with you every step of the way.

We understand that no clinical trial looks the same. Your trials deserve solutions backed by decades of therapeutically relevant and adaptable expertise. That’s exactly what we bring to the table.

When you partner with Worldwide, we’ll stay by your side through the entire lifecycle of product development with nimble, solutions that are never “just off the shelf” but customized for you and your specific needs.

Let’s work together to bring clarity to complex drug development.

Ready to work with a CRO partner who gives you our full attention?

Where in the world is Worldwide? If you’ll be at an upcoming event, let’s connect! Here’s where we’ll be:

4worldlovers: On May 22, 2023 recruitment to the Warsaw PhD School in Natural and BioMedical Sciences starts!

The IOC PAS is a leading Polish research unit conducting research in the field of organic chemistry. The main lines of research concern the methodology of organic synthesis, catalysis and the study of reaction mechanisms. The chemistry of porphyrinoids, supramolecular chemistry and computer-aided organic synthesis are being intensively developed on the basis of the CHEMATICA program, recognized by the Chemistry World journal as one of the 10 most important discoveries of 2019. The Institute is authorized to award doctoral and postdoctoral degrees in chemical sciences. Currently, the research is conducted by 135 researchers, including 14 with the title of professor and 45 doctoral students.

Grants are implemented by the Institute, including 43 grants from the National Science Center and 4 grants from the EU

Papers were published by the Institute's employees in 2022, including 18 with IFs above 10

Generowanie i ocena in silico sprofilowanych zbiorów cząsteczek i reakcji organicznych o zadanych właściwościach

4worldlovers:
We create the National Centre for Advanced Analysis of Biological and Biomedical Imaging